DIMENSIONALITY OF VALUE- ARE THE US AND EUROPE MOVING TOWARDS SIMILAR OR DIFFERENT DEFINITIONS OF PHARMACEUTICAL VALUE?

Author(s)

Capuano C¹, Bower D¹, Yampolsky D¹, Curran K¹, Suponcic S²
¹Navigant Life Sciences, Boston, MA, USA, ²Navigant Life Sciences, Lawrenceville, NJ, USA

Presentation Documents

PHP153--strong-u-capuano-c-u-sup-1-sup-strong-bower-d-sup-1-sup-yampolsky-d-sup-1-sup-curran-k-sup-1-sup-suponcic-s-sup-2-sup-br-sup-1-sup-navigant-life-sciences-boston-ma-usa-sup-2-sup-navigant-life-sciences-lawrenceville-nj-usa

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PHP153

Topic

Health Policy & Regulatory, Health Service Delivery & Process of Care, Health Technology Assessment

Topic Subcategory

Decision & Deliberative Processes, Hospital and Clinical Practices, Reimbursement & Access Policy

Disease

Multiple Diseases

Explore Related HEOR by Topic

Health Policy
Healthcare Delivery
Health Technology Assessment

Presentation